Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.
作者信息
Gueli Angela, Gottardi Daniela, Hu Huijing, Ricca Irene, De Crescenzo Alberto, Tarella Corrado
机构信息
Haematology and Cell Therapy Unit, Umberto I Hospital, Turin, Italy.
出版信息
Blood Transfus. 2013 Apr;11(2):311-4. doi: 10.2450/2012.0166-12. Epub 2013 Jan 22.
Abstract
摘要
相似文献
1
Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.利妥昔单抗联合苯达莫司汀治疗既往化疗免疫治疗难治性冷凝集素溶血性贫血的疗效：一例报告
Blood Transfus. 2013 Apr;11(2):311-4. doi: 10.2450/2012.0166-12. Epub 2013 Jan 22.
2
Therapy for chronic cold agglutinin disease: perspective for further improvements.慢性冷凝集素病的治疗：进一步改善的前景。
Blood Transfus. 2013 Apr;11(2):167-8. doi: 10.2450/2013.0273-12. Epub 2013 Jan 22.
3
Bendamustine and rituximab in relapsed and refractory hairy cell leukemia.苯达莫司汀和利妥昔单抗治疗复发难治性毛细胞白血病。
Clin Cancer Res. 2013 Nov 15;19(22):6313-21. doi: 10.1158/1078-0432.CCR-13-1848. Epub 2013 Oct 4.
4
HBV reactivation in malignant lymphoma patients treated with rituximab and bendamustine.
Int J Hematol. 2012 May;95(5):588-91. doi: 10.1007/s12185-012-1050-9. Epub 2012 Mar 16.
5
[Alleviated anemia by bendamustine in cold agglutinin disease associated with small lymphocytic lymphoma].苯达莫司汀缓解与小淋巴细胞淋巴瘤相关的冷凝集素病中的贫血
Rinsho Ketsueki. 2015 Feb;56(2):204-9. doi: 10.11406/rinketsu.56.204.
6
Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome.利妥昔单抗和苯达莫司汀成功治疗1例新诊断的华氏巨球蛋白血症合并宾-尼尔综合征患者。
Am J Hematol. 2015 Aug;90(8):E152-3. doi: 10.1002/ajh.24059. Epub 2015 May 29.
7
Long lasting remission by rituximab in a patient with primary cold agglutinin autoimmune haemolytic anaemia.利妥昔单抗治疗原发冷自身免疫性溶血性贫血患者获得持久缓解。
Wien Klin Wochenschr. 2011 Nov;123(21-22):680-3. doi: 10.1007/s00508-011-0060-6. Epub 2011 Sep 28.
8
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).苯达莫司汀和利妥昔单抗联合治疗慢性淋巴细胞白血病相关自身免疫性溶血性贫血：法国 CLL 协作组（GCFLLC/MW 和 GOELAMS）的一项多中心回顾性研究。
Am J Hematol. 2015 Mar;90(3):204-7. doi: 10.1002/ajh.23909. Epub 2015 Jan 16.
9
A case of autoimmune haemolytic anaemia achieving complete response with rituximab.1例使用利妥昔单抗获得完全缓解的自身免疫性溶血性贫血病例。
J Pak Med Assoc. 2014 Jun;64(6):700-2.
10
Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine.利妥昔单抗联合苯达莫司汀治疗B细胞慢性淋巴细胞白血病相关的I型膜增生性肾小球肾炎缓解
Clin Nephrol. 2008 Apr;69(4):285-9. doi: 10.5414/cnp69285.
引用本文的文献
1
A middle-aged woman with the initial symptom of acrocyanosis diagnosed with cold agglutinin disease: A case report.一名以手足发绀为初始症状并被诊断为冷凝集素病的中年女性：病例报告。
SAGE Open Med Case Rep. 2025 May 17;13:2050313X251342166. doi: 10.1177/2050313X251342166. eCollection 2025.
2
Cold agglutinin disease.冷凝集素病
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):226-231. doi: 10.1182/asheducation-2016.1.226.
3
Role of Complement in Autoimmune Hemolytic Anemia.补体在自身免疫性溶血性贫血中的作用。
Transfus Med Hemother. 2015 Sep;42(5):303-10. doi: 10.1159/000438964. Epub 2015 Sep 7.
4
Two cases of primary cold agglutinin disease associated with megaloblastic anemia.两例与巨幼细胞贫血相关的原发性冷凝集素病
Case Rep Hematol. 2015;2015:913795. doi: 10.1155/2015/913795. Epub 2015 Mar 30.
5
Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.自身免疫性溶血性贫血中的红细胞破坏：补体的作用及潜在的新治疗靶点
Biomed Res Int. 2015;2015:363278. doi: 10.1155/2015/363278. Epub 2015 Jan 29.
6
Therapy for chronic cold agglutinin disease: perspective for further improvements.慢性冷凝集素病的治疗：进一步改善的前景。
Blood Transfus. 2013 Apr;11(2):167-8. doi: 10.2450/2013.0273-12. Epub 2013 Jan 22.
本文引用的文献
1
Rituximab therapy for autoimmune haematological diseases.利妥昔单抗治疗自身免疫性血液系统疾病。
Eur J Intern Med. 2011 Jun;22(3):220-9. doi: 10.1016/j.ejim.2010.12.016. Epub 2011 Jan 31.
2
Bendamustine's emerging role in the management of lymphoid malignancies.苯达莫司汀在淋巴恶性肿瘤治疗中的新作用。
Semin Hematol. 2011 Apr;48 Suppl 1:S24-36. doi: 10.1053/j.seminhematol.2011.03.004.
3
How I manage cold agglutinin disease.冷抗体自身免疫性溶血性贫血的诊治策略
Br J Haematol. 2011 May;153(3):309-17. doi: 10.1111/j.1365-2141.2011.08643.x. Epub 2011 Mar 8.
4
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease.氟达拉滨和利妥昔单抗联合治疗慢性冷凝集素病的高反应率和持久缓解。
Blood. 2010 Oct 28;116(17):3180-4. doi: 10.1182/blood-2010-06-288647. Epub 2010 Jul 15.
5
Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group.利妥昔单抗联合DHAP方案挽救性化疗用于复发非霍奇金淋巴瘤：北中部癌症治疗组的一项II期试验
Leuk Lymphoma. 2008 Jun;49(6):1074-80. doi: 10.1080/10428190801993470.
6
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.利妥昔单抗可提高高危滤泡性和弥漫性大B细胞淋巴瘤自体移植高剂量化疗的疗效：一项意大利淋巴瘤创新治疗多中心调查。
J Clin Oncol. 2008 Jul 1;26(19):3166-75. doi: 10.1200/JCO.2007.14.4204. Epub 2008 May 19.
7
Rituximab in the treatment of autoimmune haematological disorders.利妥昔单抗治疗自身免疫性血液系统疾病
Br J Haematol. 2008 Apr;141(2):149-69. doi: 10.1111/j.1365-2141.2008.07054.x. Epub 2008 Mar 3.
8
Bendamustine in non-Hodgkin lymphoma: the double-agent that came from the Cold War.苯达莫司汀治疗非霍奇金淋巴瘤：源自冷战时期的双功能药物。
Clin Lymphoma Myeloma. 2007 Dec;8 Suppl 1:S13-7. doi: 10.3816/clm.2007.s.028.
9
Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents.与其他烷化剂相比，苯达莫司汀（Treanda）表现出独特的细胞毒性模式和独特的作用机制特点。
Clin Cancer Res. 2008 Jan 1;14(1):309-17. doi: 10.1158/1078-0432.CCR-07-1061.
10
Rituximab therapy in malignant lymphoma.利妥昔单抗治疗恶性淋巴瘤。
Oncogene. 2007 May 28;26(25):3603-13. doi: 10.1038/sj.onc.1210376.
Zotero 插件